furosemide has been researched along with Atherogenesis in 5 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We examined diuretic response (defined as Δ weight kg/40 mg furosemide) in 1745 hospitalized acute heart failure patients from the PROTECT trial." | 5.19 | Diuretic response in acute heart failure: clinical characteristics and prognostic significance. ( Bloomfield, DM; Cleland, JG; Cotter, G; Damman, K; Davison, B; Dittrich, HC; Fiuzat, M; Givertz, MM; Hillege, HL; Massie, BM; Metra, M; O'Connor, CM; Ponikowski, P; Teerlink, JR; Valente, MA; Van Veldhuisen, DJ; Voors, AA, 2014) |
| "Atherosclerotic renal artery stenosis has a range of manifestations depending on the severity of vascular occlusion." | 1.37 | Blood oxygen level-dependent magnetic resonance imaging identifies cortical hypoxia in severe renovascular disease. ( Crane, JA; Glockner, JF; Gloviczki, ML; Grande, JP; Lerman, LO; McKusick, MA; Misra, S; Textor, SC, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Valente, MA | 2 |
| Voors, AA | 3 |
| Damman, K | 2 |
| Van Veldhuisen, DJ | 2 |
| Massie, BM | 1 |
| O'Connor, CM | 2 |
| Metra, M | 2 |
| Ponikowski, P | 2 |
| Teerlink, JR | 2 |
| Cotter, G | 2 |
| Davison, B | 2 |
| Cleland, JG | 2 |
| Givertz, MM | 2 |
| Bloomfield, DM | 2 |
| Fiuzat, M | 1 |
| Dittrich, HC | 2 |
| Hillege, HL | 2 |
| ter Maaten, JM | 1 |
| Bruno, N | 1 |
| Vaduganathan, M | 1 |
| Kumar, V | 1 |
| Butler, J | 1 |
| Gloviczki, ML | 1 |
| Glockner, JF | 1 |
| Crane, JA | 1 |
| McKusick, MA | 1 |
| Misra, S | 1 |
| Grande, JP | 1 |
| Lerman, LO | 1 |
| Textor, SC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Open-label Study of Dapagliflozin in Patients With or Without Type 2 Diabetes Admitted With Acute Heart Failure[NCT04298229] | Phase 3 | 240 participants (Actual) | Interventional | 2020-04-01 | Completed | ||
| Impact of Sodium-glucose Cotransporter Type 2 Inhibitors on the Course of Cardiorenal Syndrome in Acute Decompensation of Chronic Heart Failure[NCT04778787] | Phase 4 | 370 participants (Actual) | Interventional | 2021-01-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for furosemide and Atherogenesis
| Article | Year |
|---|---|
Diuretic response in acute heart failure: clinical characteristics and prognostic significance.
Topics: Acute Disease; Aged; Analysis of Variance; Atherosclerosis; Bumetanide; Diabetes Complications; Diur | 2014 |
4 other studies available for furosemide and Atherogenesis
| Article | Year |
|---|---|
What Is Your Diagnosis?
Topics: Animals; Atherosclerosis; Bird Diseases; Cardiotonic Agents; Diagnosis, Differential; Diuretics; Ech | 2018 |
A combined clinical and biomarker approach to predict diuretic response in acute heart failure.
Topics: Acute Disease; Atherosclerosis; Biomarkers; Clinical Trials, Phase III as Topic; Diuretics; Electrol | 2016 |
Unsolved challenges in diuretic therapy for acute heart failure: a focus on diuretic response.
Topics: Acute Disease; Atherosclerosis; Diuretics; Dose-Response Relationship, Drug; Furosemide; Heart Failu | 2015 |
Blood oxygen level-dependent magnetic resonance imaging identifies cortical hypoxia in severe renovascular disease.
Topics: Aged; Atherosclerosis; Cell Hypoxia; Diuretics; Furosemide; Hemoglobins; Humans; Hypertension; Hyper | 2011 |